Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone

For more than 20 years, Copaxone (glatiramer acetate, Teva), a non-biological complex drug, has been a safe and effective treatment option for multiple sclerosis. In 2016, a follow-on glatiramer acetate product (FOGA, Synthon) was approved in the EU. Traditional bulk-based methods and high-resolutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Melamed-Gal, S., Loupe, P., Timan, B., Weinstein, V., Kolitz, S., Zhang, J., Funt, J., Komlosh, A., Ashkenazi, N., Bar-Ilan, O., Konya, A., Beriozkin, O., Laifenfeld, D., Hasson, T., Krispin, R., Molotsky, T., Papir, G., Sulimani, L., Zeskind, B., Liu, P., Nock, S., Hayden, M.R., Gilbert, A., Grossman, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073084/
https://www.ncbi.nlm.nih.gov/pubmed/30094354
http://dx.doi.org/10.1016/j.ensci.2018.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073084/
https://www.ncbi.nlm.nih.gov/pubmed/30094354
http://dx.doi.org/10.1016/j.ensci.2018.05.006

Ejemplares similares